Multi-Regional Trials Prompt FDA Interest In Sponsors' Trial Infrastructure Decisions
This article was originally published in The Pink Sheet Daily
Executive Summary
The need to ensure data quality necessitates a better understanding of how the data was collected, CDER's Robert O'Neill tells DIA.